Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2013
11/05/2013US8575377 Synthesis of long-chain polyunsaturated fatty acids by recombinant cell
11/05/2013US8575329 siRNA targeting kinase insert domain receptor (KDR)
11/05/2013US8575328 Formicidae (ant) control using double-stranded RNA constructs
11/05/2013US8575327 Conserved HBV and HCV sequences useful for gene silencing
11/05/2013US8575323 Thermophilic and thermoacidophilic sugar transporter genes and enzymes from Alicyclobacillus acidocaldarius and related organisms, methods
11/05/2013US8575322 Polynucleotide and polypeptide sequence and methods thereof
11/05/2013US8575316 Anti-Siglec-15 antibody
11/05/2013US8575310 Bioactive pentapeptides from rice bran and use thereof
11/05/2013US8575304 MEK ligands and polynucleotides encoding MEK ligands
11/05/2013US8575126 Conjugate constructs, delivery, and use for treatment of disease
11/05/2013US8575125 Selective inhibitors of CB2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
11/05/2013US8575124 Compositions and methods for treating cancer
11/05/2013US8575123 Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
11/05/2013US8575121 Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
11/05/2013US8575120 Genetic alterations on chromosome 12 and methods of use thereof for the diagnosis and treatment of type 1 diabetes
11/05/2013US8574911 Production and use of yeast having increased cellulose hydrolysis ability
11/05/2013US8574910 Site-specific integration and stacking of transgenes in soybean via DNA recombinase mediated cassette exchange
11/05/2013US8574909 Saccharomyces cerevisiae yeast strain with functional expression of a GLUT transporter gene
11/05/2013US8574901 Cryoconserved mature dendritic cells
11/05/2013US8574900 Nucleic acid silencing sequences
11/05/2013US8574898 Translation-coupling systems
11/05/2013US8574892 Methods and apparatus for nucleic acid sequencing by signal stretching and data integration
11/05/2013US8574886 Methods for producing hyaluronan in a recombinant host cell
11/05/2013US8574884 Thermostable neutral metalloproteases
11/05/2013US8574882 Thermostable 1,5-anhydroglucitol dehydrogenase, and method for measurement of 1,5-anhydroglucitol by using the same
11/05/2013US8574877 Production of fatty alcohols with fatty alcohol forming acyl-CoA reductases (FAR)
11/05/2013US8574857 Method and means for treatment of osteoarthritis
11/05/2013US8574623 Therapeutic agent for pulmonary fibrosis
11/05/2013US8574591 Multi plasmid system for the production of influenza virus
11/05/2013US8574590 Lipoparticles comprising proteins, methods of making, and using the same
11/05/2013US8574586 KDR peptides and vaccines comprising the same
11/05/2013US8574585 KDR peptides and vaccines comprising the same
11/05/2013US8574584 EphA2 T cell epitopes and uses therefor
11/05/2013CA2690395C Use of bi-specific antibodies for pre-targeting diagnosis and therapy
11/05/2013CA2645663C Detection of molecular interactions using a reduced affinity enzyme complementation reporter system
11/05/2013CA2529103C Use of a recombinant vector encoding il-10 for treating neuropathic pain
11/05/2013CA2512673C 2-o sulfatase compositions and related methods
11/05/2013CA2507811C Process for the determination of the primary structure of the messenger rna coding for the human recombinant endooligopeptidase a (heopa) [af217798]
11/05/2013CA2505849C Novel tricistronic vectors and uses therefor
11/05/2013CA2467936C Method of inhibiting gene expression
11/05/2013CA2398979C Novel bee venom polypeptides and methods of use thereof
11/05/2013CA2394015C Tweak receptor
11/05/2013CA2364417C Peroral gene therapy of diabetes and obesity
11/05/2013CA2328403C Basb029 polynucleotide(s) and polypeptides from neisseria meningitidis
10/2013
10/31/2013WO2013163633A1 Anti-gcc antibody molecules and use of same to test for susceptibility to gcc-targeted therapy
10/31/2013WO2013163613A2 Compositions and methods for modulating the sensitivity of cells to ahas inhibitors
10/31/2013WO2013163434A1 Recombinant cells and methods of using such cells to identify circadian rhythm modulators
10/31/2013WO2013163430A2 Serpinc1 irna compositions and methods of use thereof
10/31/2013WO2013163428A1 Detection of ret fusions in cancer
10/31/2013WO2013163423A1 Compositions and methods for wound healing and tissue repair
10/31/2013WO2013163394A1 Nuclease-mediated targeting with large targeting vectors
10/31/2013WO2013163346A1 Synthetic promoter for modulating gene expression
10/31/2013WO2013163263A2 Methods for sorting nucleic acids and multiplexed preparative in vitro cloning
10/31/2013WO2013163258A1 Microrna compounds and methods for modulating mir-21 activity
10/31/2013WO2013163210A1 Method and system for detection of an organism
10/31/2013WO2013163207A1 Identification of 5-methyl-c in nucleic acid templates
10/31/2013WO2013163085A2 Glycaspis brimblecombei control agents
10/31/2013WO2013162760A1 Novel cyclotides with anticancer activity
10/31/2013WO2013162746A1 Staphylococcal coagulase antigens and methods of their use
10/31/2013WO2013162729A1 Method for delivery of small molecules and proteins across the cell wall of algae using molecular transporters
10/31/2013WO2013162651A1 Biomarkers of immune dysfunction in response to chronic stress, methods of use and diagnostic kits
10/31/2013WO2013162445A1 Human carbonic anhydrase ii with increased physical stability
10/31/2013WO2013162363A1 RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
10/31/2013WO2013162350A2 Circular antiviral rna
10/31/2013WO2013162286A1 Marker for detecting potency of adipose-derived stem cells, and use thereof
10/31/2013WO2013162133A1 Method for detecting existence of heavy metals in mine soil using changes in expression of mtl-2 gene in caenorhabditis elegans
10/31/2013WO2013162109A1 Polymerase chain reaction primer and probe for detecting hepatitis b virus, and detection kit and method using same
10/31/2013WO2013162064A1 Urokinase-type plasminogen activator transgenic mouse
10/31/2013WO2013162054A1 Composition for controlling chromatin structure
10/31/2013WO2013162050A1 Lactoferrin fusion protein and method for producing same
10/31/2013WO2013162041A1 Unit structure-type pharmaceutical composition for nucleic acid delivery
10/31/2013WO2013162035A1 Modified amadoriase capable of acting on fructosyl hexapeptide
10/31/2013WO2013162027A1 Neuronal differentiation promoter
10/31/2013WO2013162026A1 Method for amplifying nucleic acid and method for detecting amplified nucleic acid
10/31/2013WO2013162021A1 Prophylactic or therapeutic agent for hepatic diseases
10/31/2013WO2013161964A1 Nucleic acid molecules for highly sensitive detection of ligands, screening method for nucleic acid molecules, and optimization method for sensitivity of nucleic acid molecules
10/31/2013WO2013161958A1 Novel expression vector
10/31/2013WO2013161832A1 Method for culturing microalga, biofilm formed on surface of liquid by said culturing method, biomass and oil both produced from said biofilm, method for collecting said biofilm, method for producing biomass fuel, microalga capable of forming biofilm on surface of liquid, biofilm formed on surface of liquid using said microalga, and biomass and oil both produced from said biofilm
10/31/2013WO2013161814A1 Anti-human cd69 antibody, and use thereof for medical purposes
10/31/2013WO2013161359A1 Enteral environment-improving agent
10/31/2013WO2013160865A1 Immunotolerizing fusion proteins for treatment of multiple sclerosis
10/31/2013WO2013160642A2 Wound treatment
10/31/2013WO2013160563A1 Method for competitive allele-specific cdna synthesis and differential amplification of the cdna products
10/31/2013WO2013160491A1 Tumour biomarker of the affected status of non-sentinel lymph nodes
10/31/2013WO2013160474A2 miRNAs EXPRESSION IN HEMATOLOGICAL DISEASES
10/31/2013WO2013160393A1 HIGH COMPLEXITY siRNA POOLS
10/31/2013WO2013160316A1 Polypeptide expression method
10/31/2013WO2013160270A1 Ampicillin resistant texturizing lactic acid bacteria strains
10/31/2013WO2013160230A1 Targeted genome engineering in plants
10/31/2013WO2013159879A1 Inhibitors of thioredoxin-interacting protein (txnip) for therapy
10/31/2013WO2013159710A1 Method for improving xylose consumption rate of clostridium beijerinckii
10/31/2013WO2013159234A1 Glycoengineered outer membrane vesicles and use thereof as vaccines
10/31/2013WO2013159227A1 Bitter taste receptor constitutively active mutants
10/31/2013WO2013159149A1 High oleic acid oils
10/31/2013WO2013142380A9 Oncovector nucleic acid molecules and methods of use
10/31/2013WO2013115926A3 Aspartyl-trna synthetase-fc conjugates
10/31/2013WO2013114240A3 Method for obtaining glycoprotein composition
10/31/2013WO2013111016A3 Biomolecule isolation
10/31/2013WO2013105022A3 Rnai agents to treat beta-catenin related diseases
10/31/2013WO2013101993A3 Dual variable domain immunoglobulins against receptors
1 ... 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 ... 4023